Found: 26
Select item for more details and to access through your institution.
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 2, p. 511, doi. 10.1007/s00432-018-2819-x
- By:
- Publication type:
- Article
Non-invasive CT radiomic biomarkers predict microsatellite stability status in colorectal cancer: a multicenter validation study.
- Published in:
- European Radiology Experimental, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41747-024-00484-8
- By:
- Publication type:
- Article
The Landscape of Actionable Gene Fusions in Colorectal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 21, p. 5319, doi. 10.3390/ijms20215319
- By:
- Publication type:
- Article
The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 17, p. 4263, doi. 10.3390/ijms20174263
- By:
- Publication type:
- Article
DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non-Small-Cell Lung Cancer: An External Validation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01369
- By:
- Publication type:
- Article
Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 223, doi. 10.3390/cancers11020223
- By:
- Publication type:
- Article
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11287-2
- By:
- Publication type:
- Article
Management of patients with locally recurrent rectal cancer with a previous history of distant metastases: retrospective cohort study.
- Published in:
- BJS Open, 2024, v. 8, n. 3, p. 1, doi. 10.1093/bjsopen/zrae061
- By:
- Publication type:
- Article
Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.780716
- By:
- Publication type:
- Article
Early onset metastatic colorectal cancer in patients receiving panitumumab‐based upfront strategy: Overall and sex‐specific outcomes in the Valentino trial.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 10, p. 1760, doi. 10.1002/ijc.34156
- By:
- Publication type:
- Article
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 4, p. 450, doi. 10.1016/j.clcc.2023.08.005
- By:
- Publication type:
- Article
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population.
- Published in:
- Clinical Colorectal Cancer, 2020, v. 19, n. 3, p. 219, doi. 10.1016/j.clcc.2020.04.009
- By:
- Publication type:
- Article
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan.
- Published in:
- Clinical Colorectal Cancer, 2020, v. 19, n. 3, p. 156, doi. 10.1016/j.clcc.2020.05.004
- By:
- Publication type:
- Article
Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 10, p. 1619, doi. 10.1038/s41416-023-02444-2
- By:
- Publication type:
- Article
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 3, p. 449, doi. 10.1038/s41416-021-01591-8
- By:
- Publication type:
- Article
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 4, p. 529, doi. 10.1007/s11523-021-00819-0
- By:
- Publication type:
- Article
Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. 1079, doi. 10.1002/onco.13926
- By:
- Publication type:
- Article
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability‐High End‐Stage Cancers and Poor Performance Status Related to High Disease Burden.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. 803, doi. 10.1634/theoncologist.2020-0014
- By:
- Publication type:
- Article
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD‐L1 in Gastric Cancer Patients Treated with Either Adjuvant 5‐FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA‐S Trial
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e460, doi. 10.1634/theoncologist.2019-0471
- By:
- Publication type:
- Article
Squamous Cell Carcinoma of the Oral Cavity in a Woman With a 9-Year History of Ovarian Cancer: Is Exposure to Pegylated Liposomal Doxorubicin a Factor?
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39525-3
- By:
- Publication type:
- Article
EGFR Amplification in Metastatic Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article